Search clinical trials for: PROSTVAC (rilimogene galvacirepvec/rilimogene glafolivec) -V/TRICOM

Total 9 results

National Cancer Institute (NCI)

Completed

Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Stage I Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7

United States
National Cancer Institute (NCI)

Completed

Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

Prostatic Neoplasms | Prostate Cancer | Neoplasms, Prostate

United States
National Cancer Institute (NCI)

Completed

A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Sequential Vaccinations in Prostate Cancer Patients

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Vaccine and Antibody Treatment of Prostate Cancer

Prostatic Neoplasms

United States

3

Subscribe